Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
about
Is There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsA Universal Influenza Vaccine Can Lead to Disease Exacerbation or Viral Control Depending on Delivery StrategiesDC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo.Targeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesDendritic cell and antigen dispersal landscapes regulate T cell immunity.Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma.Liposomal adjuvant development for leishmaniasis vaccines.Development of an adenovirus vector vaccine platform for targeting dendritic cells.Tolerance through Education: How Tolerogenic Dendritic Cells Shape Immunity.Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses.Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.Nanoparticles: augmenting tumor antigen presentation for vaccine and immunotherapy treatments of cancer.CLEC10A Is a Specific Marker for Human CD1c+ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion.Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope
P2860
Q28072532-4D959F39-0734-4528-BABE-F69E5CA14928Q28354202-E37F3A5C-035E-4AB0-B4C6-5AE7B3FE450EQ33627385-886E6591-57EE-4264-B7E4-AE0879B6537AQ39448911-7BF1714B-F03E-408B-A24D-A0758AA65523Q40077299-2EB6D5A4-016E-4CB6-94CC-13BBD18ED74AQ47134263-7A82FBAF-31E2-4209-B235-D29A18B7C5E6Q47153161-C1556822-0E82-4773-B566-7FC5301D0978Q47248134-50946FFF-993C-4E14-BEB9-30818C2A6823Q49242675-EE31CE5F-4631-4358-8FC9-7FA74CF9FA8FQ52584422-1C37BFA5-4872-44BE-97BF-70C4049EA465Q52655234-F5C547A2-0E4D-4E59-AF8C-937FCDBCA3DEQ52746279-02DE02F6-60C7-42AC-8D96-1A4A28A06520Q55092014-7652CFD0-80A3-40A1-954C-C0EF462E6CCAQ58696260-04E34C5A-A423-46E8-AA5E-5202E39FEE43
P2860
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@ast
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@en
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@nl
type
label
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@ast
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@en
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@nl
prefLabel
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@ast
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@en
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@nl
P2860
P50
P3181
P356
P1433
P1476
Direct Delivery of Antigens to ...... Strategy for Future Therapies
@en
P2093
Gordon F Heidkamp
Jennifer J Lühr
P2860
P3181
P356
10.3390/VACCINES4020008
P407
P577
2016-01-01T00:00:00Z